|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review | CLAES, Marithe; Tuts, L.; ROBIJNS, Jolien; Mulders, K.; van de Werf, E.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 2 | 2024 | Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity | HAESEN, Sibren; JAGER, Manon Marie; Brillouet, Aline; DE LAAT, Iris; VASTMANS, Lotte; VERGHOTE, Eline; DELAET, Anouck; D'HAESE, Sarah; HAMAD, Ibrahim; KLEINEWIETFELD, Markus; MEBIS, Jeroen; MULLENS, Wilfried; LAMBRICHTS, Ivo; WOLFS, Esther; DELUYKER, Dorien; BITO, Virginie | Journal Contribution | A1 |
| 3 | 2023 | Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report | Verhaert, Marthe; MEBIS, Jeroen; Aspeslagh, Sandrine; von Kemp, Berlinde; Rossi, Valentina; Komorovsky, Roman; Gambaro, Alessia; Kovacs, Boldizsar; Peverelli, Marta; Jathanna, Nikesh | Journal Contribution | A1 |
| 4 | 2023 | Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study | Decoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J. | Journal Contribution | M |
| 5 | 2023 | GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative | Aftimos, P. G.; Punie, K.; Decoster, L.; de Lummen, C. Van Marcke; Hebrant, A.; Raicevic, G.; Van Valckenborgh, E.; MAES, Brigitte; Maetens, J.; Collignon, J. J.; van den Mooter, T. F. A.; Fried-Vermeij, J.; Demey, W.; Tejpar, S.; Peeters, M.; Canon, J-L.; Lybaert, W.; MEBIS, Jeroen; Rottey, S.; De Greve, J. | Journal Contribution | M |
| 6 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study | Joris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J. | Journal Contribution | M |
| 7 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 8 | 2023 | Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Tuts, Laura; Lenaerts, Melissa; Wessels, Tim; Requilé, Annelies; Luyten, Daisy; Verheezen, Jolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 9 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 10 | 2023 | A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial | ROBIJNS, Jolien; Van Bever, Leen; Hermans, Sanne; CLAES, Marithe; LODEWIJCKX, Joy; Lenaerts, Melissa; Tuts, Laura; Vandaele, Eline; Vinken, Evelien; Noé, Leen; Verboven, Katleen; MAES, Annelies; Van de Velde, Anne-Sophie; BULENS, Paul; Bulens, Philippe; Van den Bergh, Laura; MEBIS, Jeroen | Journal Contribution | A1 |
| 11 | 2022 | Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group | Vergote, I; Van Nieuwenhuysen, E; De Waele, S; Vulsteke, C; Lamot, C; Van den Bulck, H; CLAES, Nele; Graas, MP; DEBROCK, Guy; Spoormans, I; Vuylsteke, P; Honhon, B; Verhoeven, D; Daan De Maeseneer; Dirix, L; MEBIS, Jeroen; Vroman, P; Denys, H; Mena, CM; Pelgrims, G; Van Steenberghe, M; van Gorp, T; Gennigens, C | Journal Contribution | A1 |
| 12 | 2022 | PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment | Thouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P.; De Greve, J. | Journal Contribution | A1 |
| 13 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 14 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 15 | 2022 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, Jeroen | Journal Contribution | A1 |
| 16 | 2022 | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-Jean | Journal Contribution | A1 |
| 17 | 2022 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMIS- HEAD trial)" by He et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 18 | 2022 | A long‐term follow‐up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Lenaerts, Melissa; Van Bever, Leen; Claes, Stefan; Pannekoeke, Luc; Verboven, Katleen; Noé, Leen; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 19 | 2022 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, Luc | Journal Contribution | A1 |
| 20 | 2022 | The perspective of patients on the use of telemedicine in cardiovascular care | Knaepen, L.; Essarti, H.; Vervoort, Y.; Driesen , K.; MEBIS, Jeroen; Vandenberk, F.; Vanoppen, A.; DENDALE, Paul; DESTEGHE, Lien; HEIDBUCHEL, Hein | Journal Contribution | M |
| 21 | 2021 | A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis | Brufsky, A.; Kim, S. B.; Zvirbule, Z.; Eniu, A.; MEBIS, Jeroen; Sohn, J. H.; Wongchenko, M.; Chohan, S.; Amin, R.; Yan, Y.; McNally, V; Miles, D.; Loi, S. | Journal Contribution | A1 |
| 22 | 2021 | A DIGITAL AUTOMATED HEALTH MONITORING SYSTEM FOR ONCOLOGY PATIENTS DURING THE COVID-19 PANDEMIC: PRACTICAL ISSUES AND LESSONS FOR THE FUTURE | ROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 23 | 2021 | PHOTOBIOMODULATION THERAPY CAN PREVENT THE DEVELOPMENT OF SEVERE ACUTE RADIODERMATITIS IN HEAD AND NECK CANCER PATIENTS: A MULTICENTRIC, RANDOMIZED CONTROLLED TRIAL | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 24 | 2021 | THE SAFE USE OF PHOTOBIOMODULATION THERAPY IN AN ONCOLOGIC SETTING | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 25 | 2021 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 26 | 2021 | THE USE OF PHOTOBIOMODULATION THERAPY FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: PRELIMINARY RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL | LODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, S; MEBIS, Jeroen | Journal Contribution | M |
| 27 | 2021 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 28 | 2021 | Response to the Letter to the editor by Donnelly et al. regarding the article “Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)” | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, Stefan | Journal Contribution | A1 |
| 29 | 2021 | Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study | Joris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J. | Journal Contribution | M |
| 30 | 2020 | Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results | Catala, Gaetan; MEBIS, Jeroen; Jerusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van Den Broeck, Anke; Duhoux, Francois P; Machiels, Jean-Pascal | Journal Contribution | A1 |
| 31 | 2020 | PRELIMINARY RESULTS OF A MULTICENTRIC, PLACEBO-CONTROLLED CLINICAL TRIAL | ROBIJNS, Jolien; LODEWIJCKX, Joy; Puts , Sofie; Claes, Stefan; Van Bever, Leen; Busse, Lore; Colson , Dora; Kaminski, Iris; Broux, Victoria; MAES, Annelies; BULENS, Paul; Noe, Leen; Brosens, Marc; Govers, Mieke; Timmermans, An; MEBIS, Jeroen | Journal Contribution | M |
| 32 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 33 | 2020 | A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies | ROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 34 | 2019 | Quality of life, fatigue, and subjective cognitive functioning immediately and 6 months after adjuvant chemotherapy in breast cancer patients | MEBIS, Jeroen; Censabella, S; Engels, Sofie; Van Marsenille, C.; ORYE, Guy; MARQUETTE, Sophie; Vansteelant, L.; Luyten, D.; MAES, Annelies; Noé, L; BULENS, Paul | Journal Contribution | M |
| 35 | 2019 | Systematic screening and assessment of psychosocial well-being and care needs of people with cancer | SCHOUTEN, Bojoura; Avau, Bert; Bekkering, Geertruida; Vankrunkelsven, Patrick; MEBIS, Jeroen; HELLINGS, Johan; Van Hecke, Ann | Journal Contribution | A1 |
| 36 | 2019 | Low-level laser therapy for the prevention of acute radiodermatitis in breast cancer patients: a randomized, placebo-controlled clinical trial (TRANSDERMIS trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Censabella, Sandrine; Claes, Stefan; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | M |
| 37 | 2019 | Photobiomodulation therapy for acute radiodermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | A1 |
| 38 | 2019 | Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer | ROBIJNS, Jolien; Censabella, S; Claes, S; Pannekoeke, L; Bussé, L; Colson, D; Kaminski, I; Broux, V; LODEWIJCKX, Joy; Puts, S; BULENS, Paul; MAES, Annelies; Noé, L; Brosens, M; Timmermans, A; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 39 | 2018 | Photobiomodulation therapy prevents severe acute radiodermatitis: a randomized, placebo-controlled trial in breast cancer patients with clinical and objective outcome measures | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Bussé, L.; Colson, D.; Kaminksi, I.; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 40 | 2018 | Photobiomodulation prevents acute radiodermatitis: final results of a RCT in bre ast cancer patients | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Busse, L.; Kaminksi, I.; Colson, D.; MAES, Annelies; BULENS, Paul; Noe, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 41 | 2018 | Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial). | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Pannekoeke, Luc; Bussé, Lore; Colson, Dora; Kaminski, Iris; BULENS, Paul; MAES, Annelies; Noé, Leen; Brosens, Marc; Timmermans, An; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 42 | 2018 | Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Bussé, L.; Colson, D.; Kaminski, I.; LODEWIJCKX, Joy; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 43 | 2018 | Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review | COSEMANS, Charlotte; OBEN, Bénedith; ARIJS, Ingrid; Daniels, Annick; DECLERCQ, Jeroen; VANHEES, Kimberly; FROYEN, Guy; MAES, Brigitte; MEBIS, Jeroen; RUMMENS, Jean-Luc | Journal Contribution | A1 |
| 44 | 2017 | Prevention of acute radiodermatitis by photobiomodulation: preliminary results of a randomized, placebo-controlled trial in breast cancer patients | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Busse, Lore; MAES, Annelies; BULENS, Paul; HELLINGS, Niels; LAMBRICHTS, Ivo; Timmermans, An; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 45 | 2017 | THE USE OF PHOTOBIOMODULATION THERAPY FOR THE MANAGEMENT OF ORAL MUCOSITIS IN CANCER PATIENTS OTHER THAN HEAD AND NECK CANCER: TWO RETROSPECTIVE ANALYSES | ROBIJNS, Jolien; Censabella, Sandrine; Holvoet, Lien; Noe, Leen; Brosens, Marc; MAES, Annelies; BULENS, Paul; Luyten, Daisy; Joosens, Eric; HELLINGS, Niels; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 46 | 2017 | Prevention of acute radiodermatitis by photobiomodulation: preliminary results of a randomized, placebo-controlled trial in breast cancer patients | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Bussé, Lore; MAES, Annelies; BULENS, Paul; HELLINGS, Niels; LAMBRICHTS, Ivo; Timmermans, An; SOMERS, Veerle; MEBIS, Jeroen | Conference Material | C2 |
| 47 | 2017 | An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries | Body, Jean-Jacques; Gatta, Francesca; De Cock, Erwin; Tao, Sunning; Kritikou, Persefoni; Wimberger, Pauline; MEBIS, Jeroen; Peeters, Marc; Pedrazzoli, Paolo; Caraceni, Augusto; Adamo, Vincenzo; Hechmati, Guy | Journal Contribution | A1 |
| 48 | 2017 | Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? | Van Praet, Charles; Rottey, Sylvie; Van Hende, Fransien; Pelgrims, Gino; Demey, Wim; Van Aelst, Filip; Wynendaele, Wim; Gil, Thierry; Schatteman, Peter; Filleul, Bertrand; Schallier, Denis; Machiels, Jean-Pascal; Schrijvers, Dirk; Everaert, Els; D'Hondt, Lionel; Werbrouck, Patrick; Vermeij, Joanna; MEBIS, Jeroen; Clausse, Marylene; Rasschaert, Marika; Van Erps, Joanna; Verheezen, Jolanda; Van Haverbeke, Jan; Goeminne, Jean-Charles; Lumen, Nicolaas | Journal Contribution | A1 |
| 49 | 2017 | A Cochrane review on systematic screening and assessment of cancer patients' psychosocial well-being and care needs | SCHOUTEN, Bojoura; Bekkering, Geertruida; Vankrunkelsven, Patrick; MEBIS, Jeroen; VAN HOOF, Elke; HELLINGS, Johan; Van Hecke, Ann | Journal Contribution | M |
| 50 | 2017 | The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature | ROBIJNS, Jolien; Censabella, Sandrine; BULENS, Paul; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 51 | 2017 | The role of photobiomodulation therapy in the care of cancer patients: review of the literature | ROBIJNS, Jolien; Censabella, S; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Van den Bergh, L.; Claes, S.; MEBIS, Jeroen | Journal Contribution | A1 |
| 52 | 2017 | Qualitative research on the Belgian Cancer Rehabilitation Evaluation System (CARES): An evaluation of the content validity and feasibility | SCHOUTEN, Bojoura; HELLINGS, Johan; Vankrunkelsven, Patrick; MEBIS, Jeroen; BULENS, Paul; Buntinx, Frank; VANDIJCK, Dominique; Van Hoof, Elke | Journal Contribution | A1 |
| 53 | 2016 | Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors | FROYEN, Guy; Broekmans, An; Hillen, Femke; Pat, Karin; ACHTEN, Ruth; MEBIS, Jeroen; RUMMENS, Jean-Luc; Willemse, Johan; MAES, Brigitte | Journal Contribution | A1 |
| 54 | 2016 | First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation | Vulsteke, Christof; Lurquin, Eveline; Debiec-Rychter, Maria; Gheysens, Olivier; Nuyts, Sandra; Schoenaers, Joseph; POLITIS, Constantinus; MEBIS, Jeroen; Hauben, Esther; Clement, Paul M. | Journal Contribution | A1 |
| 55 | 2016 | Photobiomodulation for the prevention of radiodermatitis: Preliminary results of a randomized controlled clinical trial in breast cancer patients | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Bussé, Lore; HELLINGS, Niels; LAMBRICHTS, Ivo; Timmermans, An; MAES, Annelies; BULENS, Paul; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 56 | 2016 | Low-level laser therapy for the prevention and management of radiodermatitis in cancer patients | ROBIJNS, Jolien; MEBIS, Jeroen; Censabella, S.; BULENS, Paul; MAES, Annelies; Claes, S.; Bussé, L. | Conference Material | C2 |
| 57 | 2016 | Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program | Van Praet, Charles; Rottey, Sylvie; Van Hende, Fransien; Pelgrims, Gino; Demey, Wim; Van Aelst, Filip; Wynendaele, Wim; Gil, Thierry; Schatteman, Peter; Filleul, Bertrand; Schallier, Dennis; Machiels, Jean-Pascal; Schrijvers, Dirk; Everaert, Els; D'Hondt, Lionel; Werbrouck, Patrick; Vermeij, Joanna; MEBIS, Jeroen; Clausse, Marylene; Rasschaert, Marika; Van Erps, Joanna; Verheezen, Jolanda; Van Haverbeke, Jan; Goeminne, Jean-Charles; Lumen, Nicolaas | Journal Contribution | A1 |
| 58 | 2016 | Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypNO Stage III-N2 NSCLC after Induction Chemotherapy and Resection | BILLIET, Charlotte; Peeters, Stephanie; Decaluwe, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; HENDRIKX, Marc; De Leyn, Paul; BULENS, Paul; KARIM, Rezaul; Le Pechoux, Cecile; MEBIS, Jeroen; De Ruysscher, Dirk | Journal Contribution | A1 |
| 59 | 2016 | Letter regarding "Same strategy for pitfalls of radiotherapy in different anatomical districts" | ROBIJNS, Jolien; Censabella, S.; BULENS, Paul; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 60 | 2016 | Postoperative radiotherapy for lung cancer: Is it worth the controversy? | BILLIET, Charlotte; Peeters, Stephanie; Decaluwe, Herbert; Vansteenkiste, Johan; MEBIS, Jeroen; De Ruysscher, Dirk | Journal Contribution | A1 |
| 61 | 2016 | Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS® laser therapy in breast cancer patients | Censabella, S.; Claes, S.; ROBIJNS, Jolien; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 62 | 2016 | Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes | BILLIET, Charlotte; De Ruysscher, Dirk; Peeters, Stéphanie; Decaluwé, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; De Leyn, Paul; HENDRIKX, Marc; BULENS, Paul; Le Péchoux, Cécile; MEBIS, Jeroen | Journal Contribution | A1 |
| 63 | 2016 | Assessing cancer patients' quality of life and supportive care needs: Translation-revalidation of the CARES in Flemish and exhaustive evaluation of concurrent validity | SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; SCHROOTEN, Ward; BULENS, Paul; Buntinx, Frank; MEBIS, Jeroen; VANDIJCK, Dominique; CLEEMPUT, Irina; HELLINGS, Johan | Journal Contribution | A1 |
| 64 | 2016 | Validation of the flemish CARES, a quality of life and needs assessment tool for cancer care | SCHOUTEN, Bojoura; HELLINGS, Johan; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; Buntinx, Frank; MEBIS, Jeroen; VANDIJCK, Dominique; SCHROOTEN, Ward | Journal Contribution | A1 |
| 65 | 2015 | Thrombo-Embolic Events in Cancer Patients with Impaired Renal Function | Elalamy, I.; Canon, J.L.; Bols, A.; Lybaert, W.; Duck, L.; Jochmans, K.; Bosquée, L.; Peeters, M.; Awada, A.; Clement, P.; Holbrechts, S.; Baurain, J.F.; MEBIS, Jeroen; Nortier, J. | Journal Contribution | A1 |
| 66 | 2015 | Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: a retrospective analysis | MEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, Paul | Conference Material | C2 |
| 67 | 2015 | Low-level laser therapy as a tool for the management of radiodermatitis: a pilot study in breast cancer patients | ROBIJNS, Jolien; CENSABELLA, S.; CLAES, S.; BULENS, Paul; MEBIS, Jeroen | Conference Material | C2 |
| 68 | 2015 | Low level laser therapy for the management of radiation dermatitis: final results of the dermis trial, a pilot study in breast cancer patients | Censabella, S.; ROBIJNS, Jolien; Claes, S.; BULENS, Paul; MEBIS, Jeroen | Proceedings Paper | C1 |
| 69 | 2015 | Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: A retrospective analysis | MEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, Paul | Journal Contribution | M |
| 70 | 2014 | LOW LEVEL LASER THERAPY FOR THE MANAGEMENT OF RADIATION DERMATITIS: PRELIMINARY RESULTS OF A PILOT STUDY IN BREAST CANCER PATIENTS | CENSABELLA, S.; ROBIJNS, Jolien; CLAES, S.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | M |
| 71 | 2014 | Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy | Batair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D. | Journal Contribution | A1 |
| 72 | 2013 | ‘Screening cancer patients distress and care needs: translation and validation of the Cancer Rehabilitation Evaluation System (CARES) for the Flemish population in Belgium.’ | SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; MEBIS, Jeroen; Vandenborre, Katherine; HELLINGS, Johan | Conference Material | C2 |
| 73 | 2013 | Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report | Van Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen; MEBIS, Jeroen | Journal Contribution | A2 |
| 74 | 2013 | Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer | Baitar, A.; van Fraeyenhove, F.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D. | Journal Contribution | A1 |
| 75 | 2012 | The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years later | Vanderhaegen, J.; Paridaens, R.; Piccart, M.; Lalami, Y.; Machiels, J.P.; Jerusalem, G.; Borms, M.; Goemine, J.; MEBIS, Jeroen; Dirix, L.; Lintermans, A.; Brouckaert, O.; Neven, P. | Conference Material | C2 |
| 76 | 2012 | Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events? | MEBIS, Jeroen | Conference Material | C2 |
| 77 | 2012 | Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment). | Wolter, Pascal; Hendrickx, Tine; Renard, Vincent; MEBIS, Jeroen; Debruyne, Philip R.; Wynendaele, Wim; Schallier, Denis C. C.; Vermeij, Joanna; Nielander, Aldrik; Machiels, Jean-Pascal H.; Rottey, Sylvie; Delande, Stephanie; Goeminne, Jean-Charles; Schoffski, Patrick; De Coster, Sandra; Lacour, Valerie; Foulon, Veerle | Journal Contribution | M |
| 78 | 2012 | Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial | Llombart, Antonio; Frassoldati, Antonio; Paija, Outi; Sleeboom, Harm Peter; Jerusalem, Guy; MEBIS, Jeroen; Deleu, Ines; Miller, Joel; Schenk, Nora; Neven, Patrick | Journal Contribution | A1 |
| 79 | 2012 | Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancer | LOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, Peter | Conference Material | C2 |
| 80 | 2012 | METABOLIC PHENOTYPE BY NMR SPECTROSCOPY: A BIOMARKER FOR LUNG CANCER | LOUIS, Evelyne; REEKMANS, Gunter; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; MEBIS, Jeroen; Vandeurzen, Kurt; Darquennes, Karen; ADRIAENSENS, Peter | Conference Material | C2 |
| 81 | 2011 | Metabolic phenotyping by NMR spectroscopy: A biomarker for lung cancer | LOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, Peter | Conference Material | C2 |
| 82 | 2010 | Melanoma incidence trends in Limburg after screening and prevention campaigns | Vanstraelen, D.; Deleu, H.; VAN ROBAYS, Johan; DHollander, D.; CLOES, Edith; Lousberg, D.; Kuijpers, G.; ADRIAENS, Brecht; MEBIS, Jeroen; Mathei, Catharina; Buntinx, F. | Journal Contribution | A2 |
| 83 | 2010 | Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematological malignancy after antibiotic change: a single centre prospective study with 15 years of follow-up | MEBIS, Jeroen; Jansens, Hilde; AYELE, Girma; MOLENBERGHS, Geert; Schroyens, W.; Gadisseur, Alain; Van de Velde, An L. R.; Vrelust, Inge; Goossens, Herman; Berneman, Zwi N. | Journal Contribution | A1 |
| 84 | 2005 | Pseudo-thrombopenie. Een niet altijd even goed gekend laboartoriumfenomeen. | De Greef, Y.; Claeys, R.; MEBIS, Jeroen; Janssen, M.; Vanstraelen, D.; Madoe, V.; RUMMENS, Jean-Luc; Bries, G. | Journal Contribution | A1 |
| 85 | 2005 | Oncologische revalidatie : een stap voorwaarts in een kwaliteitsvolle zorg van de kankerpatiënt | De Greef, Y.; DENDALE, Paul; CLAES, Guido; Vanstraelen, D.; Madoe, V.; Bries, G.; MAES, Annelies; Brosens, M.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
Loading...
5
0
5
0
false